Regeneron Pharmaceuticals v. Novartis Pharma
Date
Citation Number
22-427
Federal Court
U.S. Circuit Court of Appeals for the Second Circuit
Displaying 4041 - 4060 of 38851
June 17, 2022
June 16, 2022
Statement of Commissioner Alvaro M. Bedoya Regarding Report to Congress on Combatting Online Harms Through Innovation
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
P214501
Statement of Commissioner Rebecca Kelly Slaughter Regarding the Policy Statement of the Federal Trade Commission on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P221201
Statement of Commissioner Rebecca Kelly Slaughter Regarding the Commission's Report to Congress: Combatting Online Harms Through Innovation
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P214501
Statement of Commissioner Christine S. Wilson Regarding the Combatting Online Harms Through Innovation Report
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
P214501
Statement of Commissioner Alvaro M. Bedoya Regarding the Commission's Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
P221201
Public Statement
Oral Remarks of Christine S. Wilson at Open Commission Meeting on June 16, 2022
Date
Statement of Bureau of Competition Director Holly Vedova Regarding the Decision of Utah Healthcare Competitors HCA Healthcare and Steward Health Care System to Abandon Their Proposed Merger
Date
Federal Trade Commission Bureau of Competition Director Holly Vedova issued the following statement regarding the decision by Utah healthcare competitors HCA Healthcare and Steward Health Care System...
FTC Report Warns About Using Artificial Intelligence to Combat Online Problems
Date
Today the Federal Trade Commission issued a report to Congress warning about using artificial intelligence (AI) to combat online problems and urging policymakers to exercise “great caution” about...
FTC to Ramp Up Enforcement Against Any Illegal Rebate Schemes, Bribes to Prescription Drug Middleman That Block Cheaper Drugs
Date
The Federal Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients’ access to competing lower-cost drugs. The enforcement policy...
June 15, 2022
Public Statement
Remarks of Commissioner Christine S. Wilson: An Update on Merger Enforcement
Date
Matter Number
P180200
Case Timeline Item
HCA Healthcare/Steward Health Care System, In the Matter of (timeline item) - June 15, 2022
Date
File
Case Timeline Item
RWJ Barnabas Health/Saint Peter's Healthcare System, In the Matter of (timeline item) - June 15, 2022
Date
File
Joint Motion to Dismiss Complaint
(1.51 MB)
Displaying 4041 - 4060 of 38851